| C33 | Factors associated with the willingness to pay for HIV self-testing among transgender women in Northeast Brazil | E-poster | HIV self-testing |
| C33 | Can we improve HIV self-testing outcomes through digital data capture? A retrospective review of the HIVST Challenge Fund Project in Kenya | E-poster | HIV self-testing |
| C33 | Preliminary results of AmanBol: HIV self-testing program for MSM and transgender persons in Kazakhstan | E-poster | HIV self-testing |
| C33 | The cost effectiveness and optimal configuration of oral HIV self-test kit distribution in South Africa: a model analysis | E-poster | HIV self-testing |
| C33 | Impact of a combination HIV testing package on couples' HIV testing and female awareness of male partner HIV status among pregnant women in Lusaka, Zambia: A randomized trial | E-poster | HIV self-testing |
| C33 | Mexico must promote HIV self-testing: evidence from a survey of 11,000 Mexican MSM | E-poster | HIV self-testing |
| C34 | Evaluation of isoniazid preventive therapy received by children living with HIV in Nigeria | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| C34 | Human Papilloma Virus (HPV) vaccination uptake in HIV patients: challenges during COVID-19 pandemic in Michigan, USA | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| C34 | Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: an opportunity to achieve dual elimination of HIV and viral hepatitis by 2030 | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| C35 | Demand creation and HIV self-testing delivery during COVID-19 contingency measures of physical distancing among adolescents' key population enrolled in PrEP in Brazil | On-demand oral abstract session | HIV prevention adaptations during COVID-19 |